Sibutramine (usually in the form of the hydrochloride monohydrate salt) is an oral anorexiant. Until 2010 it was marketed and prescribed as an adjunct in the treatment of exogenous obesity along with diet and exercise. It has been associated with increased cardiovascular events and strokes and has been withdrawn from the market in countries and regions including Australia,Canada,China, the European Union (EU), Hong Kong,India,Mexico, Thailand,the UK, and the United States. Formula C17H26ClN
